Thrivent Financial for Lutherans
IDNA icon

Thrivent Financial for Lutherans’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,892
Closed -$203K – 2465
2022
Q1 		$203K Buy
+5,892
New +$208K ﹤0.01% 2446
2021
Q4 		– Hold
0
– – – 720
2021
Q3 		– Hold
0
– – – 775
2021
Q2 		– Hold
0
– – – 728
2021
Q1 		– Hold
0
– – – 708
2020
Q4 		– Hold
0
– – – 468
2020
Q3 		– Hold
0
– – – 488
2020
Q2 		– Hold
0
– – – 663
2020
Q1 		– Hold
0
– – – 603

Other funds holding IDNA

WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $376B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return